A one-time treatment using small molecules to target progenitor cells, pioneered in the lab of a Harvard Stem Cell Institute researcher, may potentially restore hearing lost from some of the most common causes
Face masks and hand sanitizers are essential tools to prevent the spread of COVID-19. But what if these essentials could be supercharged? HSCI researchers are developing bioengineered protective materials, including a nasal spray that could keep the virus from entering the rest of...
HSCI, a network of the nation’s top stem cell and regenerative medicine researchers, gathers to exchange ideas and forge new collaborations to advance biomedical research.
Newly formed cochlear hair cells contain intricate hair bundles with many stereocilia (critical for sensing sound) and other components that are critical for proper function and neural transmission. Photo courtesy of Will McLean
HSCI researchers developed a drug cocktail that...
A collaborative Harvard Stem Cell Institute (HSCI), Brigham and Women's Hospital (BWH) and Johns Hopkins University (JHU) co-led team has found proof-of-concept evidence for a potential cancer treatment that...
Researchers experiment with single shot that slows rejection
A drug-secreting gel that holds back the immune system—developed to help treat diseases such as brain cancer, ulcerative colitis, and arthritis—has now been shown to slow hand transplant rejection, in rats, when delivered through a single shot. The...
by Haley Bridger, Brigham and Women's Hospital 
